Shopping cart
Your cart empty!
Terms of use dolor sit amet consectetur, adipisicing elit. Recusandae provident ullam aperiam quo ad non corrupti sit vel quam repellat ipsa quod sed, repellendus adipisci, ducimus ea modi odio assumenda.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Do you agree to our terms? Sign up
Genetic tests on IVF embryos could help women over the age of 35 conceive faster, a trial has found.
This could slash the risk of unsuccessful implantation and miscarriages, reducing the "emotional toll" of having to undergo repeated IVF cycles. Preimplantation genetic testing for aneuploidy (PGT-A) checks embryos have the correct number of chromosomes before they are implanted in the womb.
Aneuploidy is a genetic condition which means cells either have missing or extra chromosomes, compared with the normal 46, leading to miscarriages, birth defects and conditions like Down's syndrome. Women over the age of 35 are at higher risk of aneuploidy because egg quality declines with age.
The trial involved 100 women aged between 35 and 42 undergoing fertility treatment at King's Fertility, half of whom were given PGT-A tests. Researchers found that women in the group that were given the tests became pregnant in fewer tries.
There was also a higher live birth rate after up to three embryo transfers in the PGT-A group - 72% - compared with 52% in the group not given tests. PGT- A testing is not available on the NHS and does come with some risk.
The UK's fertility regulator HEFA says the test involves taking a biopsy, to remove a cell or number of cells, from an embryo which can sometimes cause damage to the embryo and prevent it from developing once it has been transferred into the womb. There is also a possibility of misdiagnosis, HEFA says.
Read more from Sky News:Study links children vaping to host of health issues Dr Yusuf Beebeejaun, of King's College London and King's Fertility, said: "The number of women starting their family above the age of 35 is increasing and women in this age group are more likely to create embryos with the wrong number of chromosomes. "This increases the risk of unsuccessful implantation and miscarriages.
"Our findings suggest that targeted use of PGT-A in this age group could help more women have a baby sooner, while also reducing the emotional toll of repeated unsuccessful cycles." Dr Sesh Sunkara, of King's College London and King's Fertility, added: "While larger multi-centre trials are needed to confirm these findings, improving treatment efficiency with a shorter time to achieving pregnancy and live birth could reduce the physical and emotional burden of IVF for women of advanced reproductive age.".